new Radiofrequency Equipment Offers Hope for Cancer Pain Relief in Antofagasta
Antofagasta, december 6, 2025 – 19:02 pm – The Antofagasta Health Service (SSA) has considerably enhanced its cancer care capabilities with the acquisition of cutting-edge radiofrequency equipment dedicated to pain management. Supported by the Regional Government and CORE regional Council, this investment positions the public healthcare network at the forefront of interventional pain treatment in the region.
SSA Director dr. Francisco Grisolía emphasized the collaborative effort behind this advancement, highlighting the strong partnership with governor Ricardo Díaz and the regional councilors. “This acquisition underscores our commitment to improving care for our community,notably in the fight against cancer,” he stated. “Following the recent expansion of chemotherapy services in Calama, this new equipment represents another crucial step in providing extensive and accessible cancer care.”
The new technology offers a beacon of hope for patients facing debilitating pain. dr. Grisolía explained that the equipment allows for targeted drug delivery directly to affected nerves using specialized needles, resulting in substantial pain reduction and improved quality of life.
Dr. Luis vieras, head of Brachytherapy at the Northern Oncology center (CON) and a specialist in chronic pain interventionism, confirmed the procedure has been successfully implemented for the past two weeks. “This represents the most advanced technology available within the public system for managing cancer-related pain,” he said.
Currently, approximately 700 patients in the region require palliative care. With the new equipment fully operational, it’s anticipated that around 140 patients will benefit in the initial phase. Dr. Vieras noted the evolution of pain management techniques at CON, from basic procedures to more sophisticated interventions, and emphasized the increased safety and efficacy offered by the new equipment.”This is a true milestone for pain management in our region.”
Patients are referred for the procedure through the Palliative Care Unit, following a rigorous clinical assessment. The interventions are meticulously guided by real-time imaging, utilizing fluoroscopy (X-ray) and ultrasound to ensure precise needle placement. This precision allows clinicians to selectively target and modulate nerves responsible for pain, providing relief without impacting mobility or causing lasting side effects. The procedure itself is relatively quick, lasting between 30 and 40 minutes, with patients typically experiencing noticeable enhancement within 7 to 14 days.
the primary beneficiaries of this technology include individuals suffering from pancreatic cancer, stomach cancer, peripheral nerve involvement, and other conditions causing severe, difficult-to-manage pain. The CON is now a macrozonal reference center for this advanced pain management technique,offering a significant improvement in care for cancer patients throughout the region.
